Pierce Kristen 4
4 · CERO THERAPEUTICS HOLDINGS, INC. · Filed Jan 9, 2026
Insider Transaction Report
Form 4
Pierce Kristen
Chief Development Officer
Transactions
- Award
Stock Option (Right to Buy)
2026-01-07+1,612,099→ 1,612,099 totalExercise: $0.06From: 2026-01-07Exp: 2036-01-06→ Common Stock (1,612,099 underlying)